Lombard Medical postpones recruitment for device trial

12/10/2008 | Reuters

Lombard Medical Technologies announced that it has halted patient enrollment for a U.S. clinical study of EndoRefix, a graft-fixation device, to reduce expenses. The firm said it is still in talks "with potential investors and expects to update the market on developments in due course."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN